Drug intelligence / Profile preview

compound alpha-ketoacid tablets

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Oral
01

Overview

Compound alpha-ketoacid tablets are a nutritional therapeutic used primarily in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) to manage protein metabolism. The tablets contain a combination of calcium salts of keto-analogues of essential amino acids (isoleucine, leucine, phenylalanine, valine, and methionine) along with specific essential amino acids (lysine, threonine, tryptophan, histidine, and tyrosine). The mechanism of action involves the transamination of these keto-analogues into their corresponding essential amino acids by utilizing nitrogen from non-essential amino acids, such as urea. This process effectively recycles nitrogenous waste, reduces urea production, and helps maintain nitrogen balance while allowing for a low-protein diet, which can delay the progression of renal failure and mitigate uremic symptoms. In the context of peritoneal dialysis, they are evaluated for their ability to improve nutritional status and combat malnutrition.

Brand names
KetosterilRenologKeto-Alphalog
Other names
alpha-keto acid tabletsketo-analogues of amino acidscompound alpha-ketoacid tablets
02

Targets

BCAT (Branched-chain-amino-acid transaminase 1)

Beyond the preview

Go deeper on compound alpha-ketoacid tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound alpha-ketoacid tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call